Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Ketofol for Sedation in Trans-esophageal Echocardiography
NCT02867930Phase 4Completed
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Jun 2016
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine and ketofol in heart valve disease and atrial septal defect (ASD) (2 arms), sponsored by Post Graduate Institute of Medical Education and Research. Primary endpoint: Time taken to achieve adequacy of sedation before probe insertion. Started Jun 2016; status: completed.
02
Drugs
dexmedetomidineketofol
03
Conditions
heart valve diseaseatrial septal defect (ASD)
Beyond the preview
Go deeper on NCT02867930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02867930.